Call Start: 08:30 January 1, 0000 9:30 AM ET
The Beauty Health Company (NASDAQ:SKIN)
Q1 2023 Earnings Conference Call
May 10, 2023 08:30 ET
Company Participants
Eduardo Rodriguez - Senior Director, M&A and Investor Relations
Andrew Stanleick - President, Chief Executive Officer & Director
Liyuan Woo - Chief Financial Officer
Conference Call Participants
Korinne Wolfmeyer - Piper Sandler & Co.
Margaret Kaczor - William Blair & Company
Olivia Tong - Raymond James & Associates
Jonathan Block - Stifel, Nicolaus & Company
Oliver Chen - TD Cowen
Allen Gong - JPMorgan Chase & Co.
Bruce Jackson - The Benchmark Company
Linda Bolton-Weiser - D.A. Davidson & Co.
Navann Ty - BNP Paribas Exane
Kyle Rose - Canaccord Genuity
Operator
Good day and welcome to The Beauty Health Company First Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Eduardo Rodriguez, Senior Director of M&A and Investor Relations. Please go ahead.
Eduardo Rodriguez
Thank you, operator and good morning, everyone. Thank you for joining The Beauty Health Company's conference call to discuss our first quarter 2023 financial results which were released this morning and can be found on our website at beautyhealth.com. We also encourage you to join the webcast available on our website which contains a presentation that will be referenced during this call. With me today are Beauty Health's President and Chief Executive Officer Andrew Stanleick; and Chief Financial Officer, Liyuan Woo.
Before we get started, I would like to remind you of the company's safe harbor language. Management may make forward-looking statements, including guidance and underlying assumptions. Forward-looking statements are based on expectations that involve risks and uncertainties that could cause actual results to differ materially. For a further discussion of risks related to our business, see our filings with the SEC. This call will present non-GAAP financial measures. Reconciliation of these non-GAAP measures to the most comparable GAAP measures are included in the earnings release furnished to the SEC and available on our website.
I will now turn the call over to Andrew.
Andrew Stanleick
Thank you, Eduardo. Good morning, everyone and thank you for joining Beauty Health's first quarter 2023 earnings call. Today, we'll discuss the drivers of our Q1 results and our raised outlook for fiscal 2023. To begin, I will discuss our performance and accomplishments for the first quarter. Later, Liyuan will provide more detail on our financial results, after which we will be happy to take your questions. As always, I want to start by thanking our Beauty Health team members, our aestheticians and provider partners who together make up our global HydraFacial Nation for their continued hard work, passion and creativity. During the first quarter, our team made meaningful progress against our 5-point master plan, positioning us well to capture the tremendous growth we see ahead for our business globally.